Top Markets
Coin of the day
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
Rang in aandelen #28168
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
Aandeelprijs
$0.5495
Laatst gesynchroniseerd: 2025-05-15
Marktkapitalisatie
$28.14M
Verandering (1 dag)
4.70%
Verandering (1 jaar)
0.00%
Land
US
Handel Enzo Biochem, Inc. (ENZ)

Categorie

Winst voor Enzo Biochem, Inc. (ENZ)
Winst in Apr 2025 TTM: $-7.84M
Volgens de meest recente financiële verslagen van Enzo Biochem, Inc. bedraagt de huidige winst van het bedrijf $-7.84M. In 2023 behaalde het bedrijf een winst van $-25.02M, een daling ten opzichte van de winst van 2022, die $-18.26M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Enzo Biochem, Inc. van 2000 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-7.84M -20.13%
2024 $-9.82M -60.77%
2023 $-25.02M 37.02%
2022 $-18.26M -331.89%
2021 $7.88M -127.61%
2020 $-28.52M -1,245.84%
2019 $2.49M -121.80%
2018 $-11.42M 371.43%
2017 $-2.42M -105.21%
2016 $46.52M -2,129.45%
2015 $-2.29M -76.86%
2014 $-9.91M -47.73%
2013 $-18.95M -53.69%
2012 $-40.92M 219.12%
2011 $-12.82M -42.40%
2010 $-22.26M -5.18%
2009 $-23.48M 115.54%
2008 $-10.89M -17.33%
2007 $-13.18M -22.54%
2006 $-17.01M -426.01%
2005 $5.22M -147.09%
2004 $-11.08M -293.52%
2003 $5.73M -44.63%
2002 $10.34M -15.46%
2001 $12.23M 59.50%
2000 $7.67M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$7.61B -97,141.19%
US
$4.76B -60,832.05%
US
- -
CN
$-252.70M 3,122.82%
US
$1.42B -18,266.29%
US